Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

UNCY Unicycive Therapeutics, Inc.

已收盘 04-13 16:00:00 EDT

6.62

-0.01

-0.15%

盘后6.62

+0.000.00%

18:49 EDT

最高6.87	最低6.49	成交量67.86万
今开6.69	昨收6.63	日振幅5.66%
总市值1.67亿	流通市值1.43亿	总股本2,524万
成交额450.30万	换手率3.13%	流通股本2,165万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":6.62,"timestamp":1776110400000,"preClose":6.63,"halted":0,"volume":678586,"hourTrading":{"tag":"盘后","latestPrice":6.62,"preClose":6.62,"latestTime":"18:49 EDT","volume":3069,"amount":20589.9116,"timestamp":1776120580237,"change":0,"changeRate":0,"amplitude":0.040785},"delay":0,"changeRate":-0.0015082956259426527,"floatShares":21645700,"shares":25237782,"eps":-1.671505,"marketStatus":"已收盘","change":-0.01,"latestTime":"04-13 16:00:00 EDT","open":6.69,"high":6.865,"low":6.49,"amount":4502970.2754282,"amplitude":0.056561,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.671505,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776153600000},"marketStatusCode":5,"adr":0,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":6.63,"preHourTrading":{"tag":"盘前","latestPrice":6.6,"preClose":6.63,"latestTime":"09:22 EDT","volume":726,"amount":4793.092293,"timestamp":1776086527037,"change":-0.03,"changeRate":-0.004525,"amplitude":0.000392},"postHourTrading":{"tag":"盘后","latestPrice":6.62,"preClose":6.62,"latestTime":"18:49 EDT","volume":3069,"amount":20589.9116,"timestamp":1776120580237,"change":0,"changeRate":0,"amplitude":0.040785},"volumeRatio":1.148626,"impliedVol":0.7591,"impliedVolPercentile":0.3611},"requestUrl":"/m/hq/s/UNCY/tweets","defaultTab":"tweets","newsList":[{"id":"1109670417","title":"更新：Unicycive Therapeutics宣布FDA受理碳酸氧镧（OLC）新药申请重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1109670417","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109670417?lang=zh_cn&edition=full","pubTime":"2026-01-29 22:16","pubTimestamp":1769696171,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics, Inc.披露，美国食品药品监督管理局（FDA）已正式接受其针对碳酸氧镧（OLC）的新药申请（NDA）重新提交。该进展标志着公司在推进该药物治疗方案方面迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187751349","title":"Unicycive Therapeutics 宣布重新提交奥拉碳酸镧新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1187751349","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187751349?lang=zh_cn&edition=full","pubTime":"2025-12-29 20:11","pubTimestamp":1767010290,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics, Inc. 已正式宣布，针对其研发药物奥拉碳酸镧的新药申请已完成重新提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190658114","title":"Unicycive Therapeutics新药申请审查预计将按《处方药使用者费用法案》在6个月内完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1190658114","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190658114?lang=zh_cn&edition=full","pubTime":"2025-12-29 20:06","pubTimestamp":1767010009,"startTime":"0","endTime":"0","summary":"根据《处方药使用者费用法案》的规定，Unicycive Therapeutics, Inc. 所提交的新药上市申请，其审查结果预计将在未来六个月内揭晓。这一关键时间节点的明确，为市场关注者提供了重要的监管进程参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163378550","title":"Unicycive Therapeutics 更新 FDA A 类会议情况，并预计在年底前重新提交 Olc NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1163378550","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163378550?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:06","pubTimestamp":1761649575,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics 更新 FDA A 类会议情况，并预计在年底前重新提交 Olc NDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508689142","title":"Unicycive Therapeutics, Inc.盘中异动 早盘股价大跌5.18%报0.582美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508689142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508689142?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:14","pubTimestamp":1738595693,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时14分，Unicycive Therapeutics, Inc.股票出现波动，股价急速跳水5.18%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为515.94%、401.47%、278.93%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为136.56%、75.23%、50.76%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231453a2381301&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231453a2381301&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507808146","title":"HC Wainwright & Co.：重申Unicycive Therapeutics(UNCY.US)评级，由买入调整至买入评级, 目标价由4.00美元调整至4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507808146","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507808146?lang=zh_cn&edition=full","pubTime":"2025-01-29 20:20","pubTimestamp":1738153253,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Unicycive Therapeutics(UNCY.US)评级，由买入调整至买入评级, 目标价由4.00美元调整至4.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29202047897460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["UNCY","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491371490","title":"Unicycive Therapeutics, Inc.盘中异动 早盘快速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491371490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491371490?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:52","pubTimestamp":1734101544,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时52分，Unicycive Therapeutics, Inc.股票出现异动，股价快速跳水5.41%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225224a1ec3c87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225224a1ec3c87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488281829","title":"Unicycive Therapeutics, Inc.盘中异动 快速跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488281829","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488281829?lang=zh_cn&edition=full","pubTime":"2024-12-04 00:44","pubTimestamp":1733244264,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日00时44分，Unicycive Therapeutics, Inc.股票出现波动，股价快速跳水5.22%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204004424abf33817&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204004424abf33817&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2487556838","title":"Unicycive Therapeutics, Inc.盘中异动 快速上涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487556838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487556838?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:43","pubTimestamp":1732891428,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时43分，Unicycive Therapeutics, Inc.股票出现波动，股价大幅上涨5.96%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224348971aa72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224348971aa72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","UNCY","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486466838","title":"Unicycive Therapeutics, Inc.盘中异动 下午盘大幅上涨5.41%报0.583美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486466838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486466838?lang=zh_cn&edition=full","pubTime":"2024-11-27 03:26","pubTimestamp":1732649199,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日03时26分，Unicycive Therapeutics, Inc.股票出现异动，股价快速上涨5.41%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127032639971a8b3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127032639971a8b3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483809095","title":"Unicycive Therapeutics, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483809095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483809095?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594685,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Unicycive Therapeutics, Inc.股票出现波动，股价快速下跌5.21%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1403.84%、19.59%、11.31%，振幅较大的相关个股有Pulmatrix, Inc.、Cargo Therapeutics, Inc.、Heron Therapeutics, Inc.，振幅分别为9.83%、8.67%、8.60%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312598e42a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312598e42a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","UNCY","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2476498120","title":"Unicycive Therapeutics, Inc.盘中异动 早盘大幅拉升5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476498120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476498120?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:41","pubTimestamp":1729172479,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时41分，Unicycive Therapeutics, Inc.股票出现波动，股价急速上涨5.66%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.涨幅较大，Notable Labs, Ltd.、Molecular Templates, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为317.36%、225.32%、146.29%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.、Tevogen Bio Holdings Inc.，振幅分别为56.36%、37.28%、28.85%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017214120ab6ad87a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017214120ab6ad87a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","UNCY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unicycive.com","stockEarnings":[{"period":"1week","weight":-0.0433},{"period":"1month","weight":-0.0582},{"period":"3month","weight":0.0728},{"period":"6month","weight":0.4932},{"period":"1year","weight":0.2507},{"period":"ytd","weight":0.149}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司是一家生物技术公司，致力于开发针对某些医疗条件的治疗方法。目前，该公司的两个项目专注于肾脏疾病。随着公司的发展和团队的建立，公司打算专注于识别肾脏疾病内外的医疗状况。该公司目前的开发项目专注于两种新疗法：碳酸氧氰，用于治疗透析慢性肾病患者的高磷血症，以及UNI494，用于治疗急性肾损伤（AKI）。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.078139},{"month":2,"riseRate":0.6,"avgChangeRate":0.088088},{"month":3,"riseRate":0.4,"avgChangeRate":0.59683},{"month":4,"riseRate":0.4,"avgChangeRate":-0.150677},{"month":5,"riseRate":0.5,"avgChangeRate":-0.066545},{"month":6,"riseRate":0,"avgChangeRate":-0.181228},{"month":7,"riseRate":0,"avgChangeRate":-0.103059},{"month":8,"riseRate":0.2,"avgChangeRate":-0.122604},{"month":9,"riseRate":0.6,"avgChangeRate":0.038818},{"month":10,"riseRate":0.8,"avgChangeRate":0.050976},{"month":11,"riseRate":0.6,"avgChangeRate":0.060673},{"month":12,"riseRate":0.4,"avgChangeRate":0.09852}],"exchange":"NASDAQ","name":"Unicycive Therapeutics, Inc.","nameEN":"Unicycive Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Unicycive Therapeutics, Inc.,UNCY,Unicycive Therapeutics, Inc.股票,Unicycive Therapeutics, Inc.股票老虎,Unicycive Therapeutics, Inc.股票老虎国际,Unicycive Therapeutics, Inc.行情,Unicycive Therapeutics, Inc.股票行情,Unicycive Therapeutics, Inc.股价,Unicycive Therapeutics, Inc.股市,Unicycive Therapeutics, Inc.股票价格,Unicycive Therapeutics, Inc.股票交易,Unicycive Therapeutics, Inc.股票购买,Unicycive Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}